Oncimmune Holdings plc (LON:ONC – Get Free Report) shares dropped 8.5% during trading on Thursday . The company traded as low as GBX 11.80 ($0.14) and last traded at GBX 11.90 ($0.14). Approximately 1,445,113 shares traded hands during mid-day trading, an increase of 550% from the average daily volume of 222,310 shares. The stock had previously closed at GBX 13 ($0.16).
Oncimmune Stock Performance
The company has a fifty day moving average of GBX 14.69 and a two-hundred day moving average of GBX 14.74. The company has a debt-to-equity ratio of 806.85, a quick ratio of 0.63 and a current ratio of 1.13. The company has a market cap of £9.12 million, a price-to-earnings ratio of -410.00 and a beta of 1.19.
About Oncimmune
Oncimmune Holdings plc, an immunodiagnostics company, develops solutions for immuno-oncology, autoimmune disease and infectious diseases in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, an immunodiagnostic blood test for detecting and identifying lung cancer; ImmunoINSIGHTS that enables life science organizations to optimize drug development and delivery; SeroTag discovery arrays for discovering and validating biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel.
Read More
- Five stocks we like better than Oncimmune
- How to Plot Fibonacci Price Inflection Levels
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- The Risks of Owning Bonds
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- MarketBeat Week in Review – 01/13 – 01/17
Receive News & Ratings for Oncimmune Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncimmune and related companies with MarketBeat.com's FREE daily email newsletter.
